SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Receptagen Ltd.
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Russell J. Gilbert who wrote (114)7/10/1998 7:07:00 PM
From: Russell J. Gilbert  Read Replies (1) of 203
 
Receptagen closed today at .05 U.S./share.
I would appreciate if there are some RCG shareholders that access this thread to try and contact management at Global Research Network in order to try and gain an understanding where the new company is planning to go. I think most RCG shareholder have a good understanding of RCG's core compentancies but it would be useful to try and gain an insight on what GRN is planning to do after the merger is completed.


Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News